Regulus Therapeutics Statistics
Total Valuation
HTZ has a market cap or net worth of $1.86 billion. The enterprise value is $21.27 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HTZ has 309.90 million shares outstanding.
Current Share Class | 309.31M |
Shares Outstanding | 309.90M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.65% |
Owned by Insiders (%) | 1.89% |
Owned by Institutions (%) | 42.64% |
Float | 121.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.21 |
Forward PS | 0.21 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | 38.67 |
P/OCF Ratio | 0.97 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 443.11 |
Financial Position
The company has a current ratio of 1.26
Current Ratio | 1.26 |
Quick Ratio | 0.69 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | 414.92 |
Interest Coverage | -0.38 |
Financial Efficiency
Return on equity (ROE) is -350.48% and return on invested capital (ROIC) is -1.35%.
Return on Equity (ROE) | -350.48% |
Return on Assets (ROA) | -1.14% |
Return on Invested Capital (ROIC) | -1.35% |
Return on Capital Employed (ROCE) | -2.13% |
Revenue Per Employee | $331,308 |
Profits Per Employee | -$98,000 |
Employee Count | 26,000 |
Asset Turnover | 0.36 |
Inventory Turnover | n/a |
Taxes
Income Tax | -476.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.01% in the last 52 weeks. The beta is 2.15, so HTZ's price volatility has been higher than the market average.
Beta (5Y) | 2.15 |
52-Week Price Change | +65.01% |
50-Day Moving Average | 6.78 |
200-Day Moving Average | 5.04 |
Relative Strength Index (RSI) | 39.67 |
Average Volume (20 Days) | 6,772,764 |
Short Selling Information
The latest short interest is 59.25 million, so 19.12% of the outstanding shares have been sold short.
Short Interest | 59.25M |
Short Previous Month | 57.43M |
Short % of Shares Out | 19.12% |
Short % of Float | 48.58% |
Short Ratio (days to cover) | 7.51 |
Income Statement
In the last 12 months, HTZ had revenue of $8.61 billion and -$2.55 billion in losses. Loss per share was -$8.30.
Revenue | 8.61B |
Gross Profit | 548.00M |
Operating Income | -440.00M |
Pretax Income | -988.00M |
Net Income | -2.55B |
EBITDA | -315.00M |
EBIT | -440.00M |
Loss Per Share | -$8.30 |
Full Income Statement Balance Sheet
The company has $503.00 million in cash and $19.92 billion in debt, giving a net cash position of -$19.41 billion or -$62.64 per share.
Cash & Cash Equivalents | 503.00M |
Total Debt | 19.92B |
Net Cash | -19.41B |
Net Cash Per Share | -$62.64 |
Equity (Book Value) | -504.00M |
Book Value Per Share | -1.63 |
Working Capital | 616.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $1.91 billion and capital expenditures -$1.86 billion, giving a free cash flow of $48.00 million.
Operating Cash Flow | 1.91B |
Capital Expenditures | -1.86B |
Free Cash Flow | 48.00M |
FCF Per Share | $0.15 |
Full Cash Flow Statement Margins
Gross margin is 6.36%, with operating and profit margins of -5.11% and -29.58%.
Gross Margin | 6.36% |
Operating Margin | -5.11% |
Pretax Margin | -35.11% |
Profit Margin | -29.58% |
EBITDA Margin | -3.66% |
EBIT Margin | -5.11% |
FCF Margin | 0.56% |
Dividends & Yields
HTZ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -137.26% |
FCF Yield | 2.59% |
Dividend Details Analyst Forecast
The average price target for HTZ is $4.18, which is -30.22% lower than the current price. The consensus rating is "Sell".
Price Target | $4.18 |
Price Target Difference | -30.22% |
Analyst Consensus | Sell |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |